Form D · Pharmaceuticals

PROMEDIOR INC

Malvern, PA · CIK 0001425549

Offering snapshot reported Mar 7, 2012 · SEC filing

Reported sold
$21.8M
Offering amount: $28M
Investors reported
11
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Feb 21, 2012
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 7, 2012Initial$21,759,050No comparison11SEC filing
Oct 17, 2011Initial$6,500,000No comparison8SEC filing
Mar 16, 2010Initial$12,000,000No comparison8SEC filing
Feb 25, 2009Initial$6,000,000No comparisonNot reportedSEC filing
Jan 29, 2008PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-174489

Source: Form D, filed Mar 7, 2012. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
James W. Broderick Director
James W. Broderick, M.D. Director
Dominick C. Colangelo Director, Executive
John Friedman Director
Paul D. Goldenheim Director
Paul D. Goldenheim, M.D. Director
Larry Kauvar Director
Mark Lupher Executive
Geert Jan Mulder Director
Amir Nashat Director
Hanns A. Pielenz Director
Harold R. Werner Director
Joseph S. Zakrzewski Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
371 Phoenixville Pike
Malvern, PA, 19355